SMT201500175B - Derivati di azaindoli come inibitori delle proteine chinasi abl e src - Google Patents
Derivati di azaindoli come inibitori delle proteine chinasi abl e srcInfo
- Publication number
- SMT201500175B SMT201500175B SM201500175T SM201500175T SMT201500175B SM T201500175 B SMT201500175 B SM T201500175B SM 201500175 T SM201500175 T SM 201500175T SM 201500175 T SM201500175 T SM 201500175T SM T201500175 B SMT201500175 B SM T201500175B
- Authority
- SM
- San Marino
- Prior art keywords
- inhibitors
- azaindole derivatives
- src proteins
- kinase abl
- abl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20227909P | 2009-02-12 | 2009-02-12 | |
| FR0900631A FR2941948B1 (fr) | 2009-02-12 | 2009-02-12 | Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src |
| PCT/IB2010/000593 WO2010092489A1 (en) | 2009-02-12 | 2010-02-12 | Derivatives of azaindoles as inhibitors of protein kinases abl and src |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201500175B true SMT201500175B (it) | 2015-09-07 |
Family
ID=40886859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201500175T SMT201500175B (it) | 2009-02-12 | 2015-07-22 | Derivati di azaindoli come inibitori delle proteine chinasi abl e src |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8580815B2 (ja) |
| EP (1) | EP2396325B1 (ja) |
| JP (1) | JP5583698B2 (ja) |
| AU (1) | AU2010212560B2 (ja) |
| CA (1) | CA2751478A1 (ja) |
| DK (1) | DK2396325T3 (ja) |
| ES (1) | ES2540962T3 (ja) |
| FR (1) | FR2941948B1 (ja) |
| HR (1) | HRP20150697T8 (ja) |
| HU (1) | HUE024989T2 (ja) |
| PL (1) | PL2396325T3 (ja) |
| PT (1) | PT2396325E (ja) |
| SI (1) | SI2396325T1 (ja) |
| SM (1) | SMT201500175B (ja) |
| WO (1) | WO2010092489A1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201504754QA (en) * | 2012-12-21 | 2015-07-30 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| FR3000493A1 (fr) * | 2012-12-28 | 2014-07-04 | Oribase Pharma | Nouveaux inhibiteurs de proteines kinases |
| FR3000494B1 (fr) * | 2012-12-28 | 2015-08-21 | Oribase Pharma | Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases |
| FR3000492B1 (fr) * | 2012-12-28 | 2015-09-11 | Oribase Pharma | Nouveaux derives azaindole en tant qu'inhibiteurs multikinases |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| AU2018238138A1 (en) * | 2017-03-21 | 2019-10-17 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
| CN111943947B (zh) * | 2020-07-24 | 2021-04-30 | 重庆文理学院 | 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用 |
| WO2022076973A1 (en) * | 2020-10-05 | 2022-04-14 | Enliven Therapeutics, Inc. | 7-azaindole compounds for inhibition of bcr-abl tyrosine kinases |
| US11767321B2 (en) | 2020-10-05 | 2023-09-26 | Enliven Inc. | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0330042D0 (en) | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
| GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
| JP2008503473A (ja) * | 2004-06-17 | 2008-02-07 | プレキシコン，インコーポレーテッド | Ｃ−ｋｉｔ活性を調節する化合物 |
| US7709645B2 (en) * | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| US7361764B2 (en) | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| MX2007001127A (es) | 2004-07-27 | 2007-07-11 | Sgx Pharmaceuticals Inc | Moduladores de pirrolo-piridina cinasa. |
| WO2006104971A1 (en) * | 2005-03-28 | 2006-10-05 | Bristol-Myers Squibb Company | Atp competitive kinase inhibitors |
| JP2010502660A (ja) * | 2006-09-06 | 2010-01-28 | エフ．ホフマン−ラ ロシュ アーゲー | プロテインキナーゼインヒビターとしてのヘテロアリール誘導体 |
| WO2008060907A2 (en) * | 2006-11-10 | 2008-05-22 | Bristol-Myers Squibb Company | Pyrrolo-pyridine kinase inhibitors |
| WO2008144253A1 (en) * | 2007-05-14 | 2008-11-27 | Irm Llc | Protein kinase inhibitors and methods for using thereof |
| CL2009000447A1 (es) * | 2008-02-29 | 2010-01-04 | Array Biopharma Inc Y Genentech Inc | Compuestos derivados de (1h-pirrolo{2,3-b}piridin-5-il)-sulfonamido-benzamida sustituida; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento del cancer, a travez de la inhibicion de raf. |
| HUE035798T2 (en) * | 2008-11-03 | 2018-05-28 | Syntarga Bv | CC-1065 analogues and conjugates |
-
2009
- 2009-02-12 FR FR0900631A patent/FR2941948B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-12 SI SI201030964T patent/SI2396325T1/sl unknown
- 2010-02-12 DK DK10710439.0T patent/DK2396325T3/en active
- 2010-02-12 WO PCT/IB2010/000593 patent/WO2010092489A1/en active Application Filing
- 2010-02-12 ES ES10710439.0T patent/ES2540962T3/es active Active
- 2010-02-12 JP JP2011549698A patent/JP5583698B2/ja not_active Expired - Fee Related
- 2010-02-12 US US13/148,988 patent/US8580815B2/en not_active Expired - Fee Related
- 2010-02-12 PT PT107104390T patent/PT2396325E/pt unknown
- 2010-02-12 CA CA2751478A patent/CA2751478A1/en not_active Abandoned
- 2010-02-12 PL PL10710439T patent/PL2396325T3/pl unknown
- 2010-02-12 HU HUE10710439A patent/HUE024989T2/en unknown
- 2010-02-12 EP EP10710439.0A patent/EP2396325B1/en not_active Not-in-force
- 2010-02-12 AU AU2010212560A patent/AU2010212560B2/en not_active Ceased
-
2015
- 2015-06-30 HR HRP20150697TT patent/HRP20150697T8/hr unknown
- 2015-07-22 SM SM201500175T patent/SMT201500175B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2941948B1 (fr) | 2013-04-05 |
| US20110312959A1 (en) | 2011-12-22 |
| ES2540962T3 (es) | 2015-07-15 |
| FR2941948A1 (fr) | 2010-08-13 |
| HUE024989T2 (en) | 2016-01-28 |
| PT2396325E (pt) | 2015-08-21 |
| AU2010212560A1 (en) | 2011-08-11 |
| EP2396325B1 (en) | 2015-04-01 |
| WO2010092489A1 (en) | 2010-08-19 |
| SI2396325T1 (sl) | 2015-08-31 |
| HRP20150697T8 (en) | 2015-11-06 |
| DK2396325T3 (en) | 2015-06-29 |
| CA2751478A1 (en) | 2010-08-19 |
| PL2396325T3 (pl) | 2015-10-30 |
| EP2396325A1 (en) | 2011-12-21 |
| JP5583698B2 (ja) | 2014-09-03 |
| HRP20150697T1 (hr) | 2015-08-14 |
| US8580815B2 (en) | 2013-11-12 |
| AU2010212560B2 (en) | 2016-01-21 |
| JP2012517465A (ja) | 2012-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201500175B (it) | Derivati di azaindoli come inibitori delle proteine chinasi abl e src | |
| SMT201600220B (it) | Derivati di eterociclile biciclici come inibitori di fgfr chinasi per uso terapeutico | |
| CY2023023I1 (el) | Παραγωγα λακταμης χρησιμα ως αναστολεις μεταλλαγμενης idh1 | |
| SMT201500195B (it) | Derivati di chinolina e chinossalina quali inibitori delle chinasi | |
| SMT201500191B (it) | Derivati di benzopirazina sostituiti come inibitori delle chinasi fgfr per il trattamento di malattie tumorali | |
| LTPA2019006I1 (lt) | Junginiai ir kompozicijos kaip proteinkinazės inhibitoriai | |
| SMT201500076B (it) | Derivati di chinazolin-4(3H)-one utilizzati come inibitori della PI3 chinasi | |
| SMT201400086B (it) | Derivati chinazolin-4(3H)-one usati come inibitoridi PI3 chinasi | |
| SMT201500200B (it) | Derivati di imidazo[1,2-a]piridina come inibitori delle chinasi fgfr per l'uso in terapia | |
| SMT201300114T1 (it) | Derivati di piridazina come inibitori di smo | |
| SMT201600005B (it) | Derivati di picolinammide quali inibitori di chinasi | |
| SMT201600338B (it) | Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt | |
| SMAP200800048A (it) | Derivati pirimidinici utilizzati come inibitori dip13-chinasi | |
| HK1215578A1 (zh) | 作為蛋白激酶抑制劑的氮雜吲哚衍生物 | |
| SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
| BRPI1012333A2 (pt) | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso | |
| SMT201700108B (it) | Derivati delle mostarde azotate | |
| SMT201400009B (it) | Derivati eteroaromatici di ariltriazolo come inibitori dell'enzima pde 10A | |
| SMT201500208B (it) | Derivati di piridinone come inibitori della transglutaminasi tissutale | |
| SMT201400155B (it) | Composizioni farmaceutiche comprendenti derivati di 2-osso-1-pirrolidina | |
| SMAP200900065A (it) | Derivati ciclizzati come inibitori di eg-5 | |
| SMT201600076B (it) | Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo | |
| BR112012006652A2 (pt) | métodos para preparar os derivados de pirimidina úteis como inibidores de proteína cinase | |
| SMT201400084B (it) | Nuovi derivati di 6-(osso-1,6diiro-pirimidin-2-il)-ammide, loro preparazione e loro uso farmaceuticocome inibitori di fosforilazione di akt | |
| SMT201300067B (it) | Applicazioni terapeutiche di derivati di chinazolindione |